Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Scottish Medical Journal|December 20, 2011
Using WHO-FRAX to describe fracture risk: experience in primary careF R MacLean, S A Thomson, S J GallacherPharmacoeconomics|December 9, 1995
Formulary management of drugs for cancer-associated hypercalcaemiaS J GallacherCalcified Tissue International|September 28, 2010
Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic reviewS J Gallacher, T DixonScottish Medical Journal|April 1, 1991
Pseudogout associated with the use of cyclical etidronate therapyS J Gallacher, I T Boyle, H A CapellInjury|July 30, 2005
Osteoporosis risk assessment and treatment intervention after hip or shoulder fracture. A comparison of two centres in the United KingdomA W Murray, C McQuillan, B Kennon, et al.Nuclear Medicine Communications|November 1, 1990
Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatmentU Patel, S J Gallacher, I T Boyle, et al.Scottish Medical Journal|October 1, 1989
The hyperthyroidism of polyostotic fibrous dysplasia--a possible autoimmune aetiologyS J Gallacher, R Wilson, I T Boyle, et al.Scottish Medical Journal|October 1, 1993
Central nervous system histiocytosis X--imaging and responses to chemotherapyE Forrest, S J Gallacher, D Hadley, et al.Annals of Internal Medicine|April 1, 1990
Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patientsS H Ralston, S J Gallacher, U Patel, et al.Pageof 8